Old Web
English
Sign In
Acemap
>
authorDetail
>
Stella Khoo
Stella Khoo
City of Hope National Medical Center
Medicine
Cancer
Drug development
Alternative medicine
Physical therapy
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Atezolizumab Combined with Immunogenic Salvage Chemoimmunotherapy (R-GemOx+Atezo) in Patients with Transformed Diffuse Large B-Cell Lymphoma
2021
Blood
Alex F. Herrera
Tamer Othman
Paul Frankel
Pamela B. Allen
Leslie Popplewell
Geoffrey Shouse
Tanya Siddiqi
Alexey V. Danilov
Nora Ruel
Shari Daniels
Lacolle Peters
Stella Khoo
Steven T. Rosen
Elad Sharon
Joseph Tuscano
Show All
Source
Cite
Save
Citations (0)
Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium - an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879.
2021
Investigational New Drugs
David I. Quinn
Denice D. Tsao-Wei
Przemyslaw Twardowski
Ana Aparicio
Paul Frankel
Gurkamal S. Chatta
John J. Wright
Susan Groshen
Stella Khoo
Heinz-Josef Lenz
Primo N. Lara
David R. Gandara
Edward M. Newman
Show All
Source
Cite
Save
Citations (2)
A mismatch between methods and objectives in phase I drug development: Statistical limitations and personalized medicine—A California Cancer Consortium (CCC) study.
2017
Journal of Clinical Oncology
Paul Frankel
Stephen Shibata
Susan Groshen
Jeff Longmate
Sumanta K. Pal
Stella Khoo
Edward M. Newman
Show All
Source
Cite
Save
Citations (0)
1